EUVIMEDEUVIMED entdecken
Crossref

Betulinic Acid Acts in Synergism with Imatinib Mesylate, Triggering Apoptosis in MDR Leukemia Cells

Claudia Stutz, Ana Paula Gregório Alves Fontão, Gustavo Werneck de Souza E Silva, Leonardo Noboru Seito, Renata Trentin Perdomo iD, André Luiz Franco Sampaio iD

Planta Medica · 01.01.2025 · 91 (01/02) · 19-28

DOI: 10.1055/a-2440-4847 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Planta Medica, erschienen am 01.01.2025. Verfasst von Claudia Stutz und 5 weiteren Autor:innen. Beteiligte Einrichtung: Fundação Oswaldo Cruz, Eusébio, CE, Brasil. Hauptthemen laut MEDLINE: Betulinic Acid, Pentacyclic Triterpenes, Apoptosis, Imatinib Mesylate. Die Arbeit nennt 60 Literaturangaben. Gefördert von: Fundação de Apoio ao Desenvolvimento do Ensino, Ciência e Tecnologia do Estado de Mato Grosso do Sul, Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro, Conselho Nacional de Desenvolvimento Científico e Tecnológico.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic myeloid leukemia (CML) is a myeloproliferative disease, characterized by the presence of the oncogene BCR-ABL. Imatinib mesylate (IMA) is the first-line treatment for CML, and some treatment resistance has been reported. Natural products are rich sources of bioactive compounds with biological effects, opening a possibility to alter cell susceptibility to drugs such as imatinib. Herein, we evaluated the interference of betulinic acid and ursolic acid in glycoprotein P (P-gp) activity and the possible synergistic effect when associated with IMA by the Chou-Talalay method. Ursolic acid presented an IC50 of 14.0 µM and 19.6 µM for K562 and Lucena 1, respectively, whilst betulinic acid presented an IC50 of 8.6 µM and 12.5 µM for these cell lines. Evaluation of the combination of terpenoids and imatinib mesylate revealed that ursolic acid or betulinic acid acts in synergism with IMA, as indicated by the combination indexes (CI

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Betulinic AcidPentacyclic TriterpenesApoptosisImatinib MesylateDrug SynergismTriterpenesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveUrsolic AcidDrug Resistance, NeoplasmHumansCell Line, TumorDrug Resistance, MultipleK562 Cells

Substanzen

Betulinic AcidPentacyclic TriterpenesImatinib MesylateTriterpenesUrsolic Acid

Autor:innen und Institutionen

  • Fundação Oswaldo Cruz, Eusébio, CE, Brasil.
  • Fundação Oswaldo Cruz, Campo Grande, MS, Brasil.
  • Laboratório de Farmacologia Molecular, Instituto de Tecnologia em Fármacos; Fiocruz, Rio de Janeiro, RJ, Brasil.
  • Laboratório de Farmacologia Aplicada, Instituto de Tecnologia em Fármacos; Fiocruz, Rio de Janeiro, RJ, Brasil.
  • Laboratório de Biologia Molecular e Culturas Celulares, Faculdade de Ciências Farmacêuticas, Alimentos e Nutrição; UFMS, Campo Grande, MS, Brasil.

ORCID-Profile: Renata Trentin Perdomo, André Luiz Franco Sampaio

Förderung

  • Fundação de Apoio ao Desenvolvimento do Ensino, Ciência e Tecnologia do Estado de Mato Grosso do Sul
  • Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico

Zitieren

APA

Stutz, C., Fontão, A. P. G. A., Silva, G. W. S. E., Seito, L. N., Perdomo, R. T., & Sampaio, A. L. F. (2025). Betulinic Acid Acts in Synergism with Imatinib Mesylate, Triggering Apoptosis in MDR Leukemia Cells. Planta Medica, 91(01/02), 19-28. https://doi.org/10.1055/a-2440-4847

Vancouver

Stutz C, Fontão APGA, Silva GWSE, Seito LN, Perdomo RT, Sampaio ALF. Betulinic Acid Acts in Synergism with Imatinib Mesylate, Triggering Apoptosis in MDR Leukemia Cells. Planta Medica. 2025;91(01/02):19-28. doi:10.1055/a-2440-4847

BibTeX
@article{Stutz2025,
  author = {Stutz, Claudia and Fontão, Ana Paula Gregório Alves and Silva, Gustavo Werneck de Souza E and Seito, Leonardo Noboru and Perdomo, Renata Trentin and Sampaio, André Luiz Franco},
  title = {Betulinic Acid Acts in Synergism with Imatinib Mesylate, Triggering Apoptosis in MDR Leukemia Cells},
  journal = {Planta Medica},
  year = {2025},
  volume = {91},
  number = {01/02},
  pages = {19--28},
  doi = {10.1055/a-2440-4847}
}
Kostenlos starten →